Evogene Ltd.

General ticker "EVGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $9.2M (TTM average)

Evogene Ltd. does not follow the US Stock Market performance with the rate: -10.9%.

Estimated limits based on current volatility of 3.9%: low 0.80$, high 0.86$

Factors to consider:

  • Total employees count: 192 as of 2013
  • Current price 31.2% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.11$, 3.95$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.14$, 3.68$]

Financial Metrics affecting the EVGN estimates:

  • Positive: with PPE of -0.5 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -229.30 <= 0.01
  • Positive: Investing cash flow per share per price, % of 111.99 > -0.63
  • Positive: Interest expense per share per price, % of 1.44 <= 3.28
  • Positive: Return on assets ratio (scaled to [-100,100]) of 31.17 > 6.11
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term EVGN quotes

Long-term EVGN plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $1.68MM $5.64MM $8.51MM
Operating Expenses $31.39MM $32.03MM $30.25MM
Operating Income $-29.71MM $-26.39MM $-21.73MM
Non-Operating Income $-0.04MM $0.40MM $3.69MM
Interest Expense $0.24MM $0.17MM $0.12MM
R&D Expense $17.53MM $18.11MM $14.26MM
Income(Loss) $-29.75MM $-25.99MM $-18.05MM
Taxes $-0.09MM $0.03MM $-0.01MM
Profit(Loss)* $-26.64MM $-23.88MM $-16.48MM
Stockholders Equity $27.93MM $12.05MM $-1.45MM
Inventory $0.57MM $0.08MM $1.82MM
Assets $56.13MM $51.10MM $39.86MM
Operating Cash Flow $-23.68MM $-21.58MM $-19.70MM
Capital expenditure $1.17MM $0.79MM $0.63MM
Investing Cash Flow $13.27MM $-4.54MM $9.62MM
Financing Cash Flow $9.34MM $18.15MM $4.66MM
Earnings Per Share** $-6.46 $-5.23 $-2.89

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.